tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Berens, 221 are a BUY (72.46%), 63 are a HOLD (20.66%), 21 are a SELL (6.89%).
Analyst Andrew Berens, currently employed at LEERINK, carries an average stock price target met ratio of 56.8% that have a potential upside of 42.56% achieved within 314 days.
Andrew Berens’s has documented 600 price targets and ratings displayed on 54 stocks. The coverage is on Healthcare, Basic Materials, Consumer Defensive, Energy, Technology sectors.
Most recent stock forecast was given on INCY, yte at 02-Aug-2026.
Analyst best performing recommendations are on ELEV (ELEVATION ONCOLOGY).
The best stock recommendation documented was for ELEV (ELEVATION ONCOLOGY) at 1/9/2023. The price target of $1 was fulfilled within 3 days with a profit of $0.2 (25%) receiving and performance score of 83.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Apr-2026
$50
$17.42 (53.47%)
$46
11 days ago
(21-Sep-2026)
1/3 (33.33%)
$16.05 (47.28%)
73
Hold Since 01-Dec-2022
$34
$1.42 (4.36%)
$31
1 months 25 days ago
(07-Aug-2026)
9/10 (90%)
$1.73 (5.36%)
123
Buy Since 05-Mar-2026
$52
$19.42 (59.61%)
$46
2 months 1 days ago
(31-Jul-2026)
1/3 (33.33%)
$21.98 (73.22%)
215
Buy Since 05-Jan-2024
$39
$6.42 (19.71%)
$41
2 months 1 days ago
(31-Jul-2026)
10/12 (83.33%)
$8.98 (29.91%)
95
Buy Since 24-Feb-2025
$55
$22.42 (68.82%)
$52
2 months 2 days ago
(30-Jul-2026)
0/12 (0%)
$22.25 (67.94%)
Which stock is Andrew Berens most bullish on?
Which stock is Andrew Berens most reserved on?
What Year was the first public recommendation made by Andrew Berens?
